| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 279 |
| 1 | TEDUGLUTIDE | 249 |
| 2 | SILDENAFIL CITRATE | 137 |
| 3 | TADALAFIL | 135 |
| 4 | CYCLOPHOSPHAMIDE | 131 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 131 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 131 |
| 7 | FUROSEMIDE | 127 |
| 8 | RITUXIMAB | 122 |
| 9 | VANCOMYCIN | 120 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEDUGLUTIDE | 249 | 0.0185 |
| 1 | ACITRETIN | 32 | 0.0065 |
| 2 | EPOPROSTENOL | 85 | 0.0065 |
| 3 | ANIDULAFUNGIN | 9 | 0.0055 |
| 4 | SIPULEUCEL-T | 29 | 0.0050 |
| 5 | MICAFUNGIN SODIUM | 30 | 0.0046 |
| 6 | CISATRACURIUM BESYLATE | 9 | 0.0040 |
| 7 | NERATINIB | 9 | 0.0039 |
| 8 | ACETYLCYSTEINE | 30 | 0.0031 |
| 9 | CEFTAZIDIME | 24 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 383 |
| 1 | Prostacycline Vasodilator [EPC] | 354 |
| 2 | GLP-2 Analog [EPC] | 249 |
| 3 | Endothelin Receptor Antagonist [EPC] | 207 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 184 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 179 |
| 6 | Loop Diuretic [EPC] | 159 |
| 7 | Alkylating Drug [EPC] | 146 |
| 8 | Glycopeptide Antibacterial [EPC] | 131 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 129 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 249 | 0.0185 |
| 1 | CD123 Interaction [EPC] | 7 | 0.0130 |
| 2 | Lipid Emulsion [EPC] | 23 | 0.0087 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 35 | 0.0060 |
| 4 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 5 | Vitamin D2 Analog [EPC] | 39 | 0.0055 |
| 6 | Autologous Cellular Immunotherapy [EPC] | 29 | 0.0050 |
| 7 | Echinocandin Antifungal [EPC] | 38 | 0.0046 |
| 8 | Plasma Kallikrein Inhibitor [EPC] | 8 | 0.0033 |
| 9 | Vasoconstrictor [EPC] | 1 | 0.0033 |